TOPK-p38/JNK-IN-1 NEW
| Price | $1520 | $1980 | $2500 |
| Package | 25mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-04-29 |
Product Details
| Product Name: TOPK-p38/JNK-IN-1 | CAS No.: 2745108-35-2 |
| Supply Ability: 10g | Release date: 2025/04/29 |
Product Introduction
Bioactivity
| Name | TOPK-p38/JNK-IN-1 |
| Description | TOPK-p38/JNK-IN-1 (Compound B12) is an orally active inhibitor of the TOPK-p38/JNK signaling pathway, exhibiting an IC50 of 2.14 μM for NO production inhibition. It demonstrates anti-inflammatory properties by inhibiting downstream protein phosphorylation and preventing TOPK degradation [1]. |
| In vitro | TOPK-p38/JNK-IN-1 (Compound B12) (10 μM, 1 h) inhibits NO production in RAW264.7 cells and suppresses LPS-induced TOPK/NF-jB/p38/JNK activation (0-10 μM, 1 h for RAW264.7; 6 h for HaCaT) [1]. It also inhibits cell proliferation in a dose-dependent manner (0-100 μM, 24 h for RAW264.7; 0-50 μM, 6 h for HaCaT) [1]. In Cell Viability Assays on RAW264.7 cells, concentrations of 4 μM, 20 μM, and 100 μM for 24 h inhibited cell proliferation dose-dependently [1]. In Cell Proliferation Assays on HaCaT cells, pre-treatment with various concentrations (0.78-50 μM) for 6 h followed by 24 h incubation with LPS (100 μg/mL) inhibited LPS-induced excessive proliferation dose-dependently [1]. Western Blot Analysis on RAW264.7 and HaCaT cells (2.5-10 μM) pre-treated for 1 h or 6 h showed dose-dependent inhibition of iNOS and COX-2 expression, affected TOPK phosphorylation, and inhibited P38/JNK protein phosphorylation and NF-κB p65 nuclear translocation [1]. |
| In vivo | TOPK-p38/JNK-IN-1 (Compound B12), administered orally at 20-40 mg/kg daily for a week to 6-8-week-old female BALB/c mice, effectively mitigated psoriasis-like skin inflammation induced by 62.5 mg of IMQ cream. Treatment significantly reduced scales, thickness, and erythema, and histopathological analysis showed alleviated hyperkeratosis, acanthocyte proliferation, and inflammatory cell infiltration. Compound B12 also dose-dependently inhibited the expression of psoriasis-related proteins (p-STAT3, p-TOPK, TOPK, p-p38, p-JNKs, PCNA, p-H2AX) in the skin tissues of the mice. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1removed |
VIP3Y
|
TargetMol Chemicals Inc.
|
2025-07-10 | |
| $39.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-05-16 | |
| $0.00/1kg |
VIP3Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2022-09-30 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY